Annual General Meeting: Approval of all Agenda Items
Merck KGaA, Darmstadt, Germany, a leading science and technology company, held its 27th Annual General Meeting in virtual form today.
The Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA, Darmstadt, Germany, for fiscal 2021 and approved all of the resolutions on the agenda, including the proposed dividend of € 1.85 per share, an increase of € 0.45 over the previous year.
Within the scope of the Annual General Meeting, shareholders voted, among other things, on a change of the statutory auditor for fiscal 2023. As proposed by the Supervisory Board, Deloitte GmbH Wirtschaftsprüfungsgesellschaft was elected as statutory auditor for fiscal 2023.
Around 90.7 million shares were represented in the vote, corresponding to 70.15% of the approximately 129.2 million shares issued. The details of the voting results and further information can be found at https://www.emdgroup.com/en/investors/events-and-presentations/annual-general-meeting.html.
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services